Sort by
Items per page

Send to

Choose Destination

Best matches for Malmström P[au]:

Search results

Items: 1 to 50 of 302


---Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy.

Sjöström M, Chang SL, Fishbane N, Davicioni E, Hartman L, Holmberg E, Feng FY, Speers C, Pierce LJ, Malmström P, Fernö M, Karlsson P.

Clin Cancer Res. 2019 Sep 26. pii: clincanres.1038.2019. doi: 10.1158/1078-0432.CCR-19-1038. [Epub ahead of print]


Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy.

Böös M, Jerlström T, Beckman E, Bläckberg M, Brändstedt J, Kollberg P, Löfgren A, Malmström PU, Sahlén G, Sörenby A, Vikerfors A, Åkesson A, Liedberg F.

Scand J Urol. 2019 Aug 6:1-5. doi: 10.1080/21681805.2019.1643912. [Epub ahead of print]


How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is Unavailable.

Witjes JA, Brausi M, Malmstrom PU.

Eur Urol Oncol. 2019 Jul 16. pii: S2588-9311(19)30092-6. doi: 10.1016/j.euo.2019.06.011. [Epub ahead of print]


Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016.

Malmström PU, Gårdmark T, Sherif A, Ströck V, Hosseini-Aliabad A, Jahnson S, Aljabery F, Liedberg F.

Scand J Urol. 2019 Jul 2:1-7. doi: 10.1080/21681805.2019.1632380. [Epub ahead of print]


Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?

Rouprêt M, Malmstrom PU, Black P.

Eur Urol Oncol. 2019 Jun 22. pii: S2588-9311(19)30078-1. doi: 10.1016/j.euo.2019.06.003. [Epub ahead of print]


Alltför många inkluderas i vårdförlopp urinblåsecancer.

Holmäng S, Hedelin H, Malmström PU.

Lakartidningen. 2019 Feb 19;116. pii: FIEY. Swedish. No abstract available.

Free Article

Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival.

Russell B, Sherif A, Häggström C, Josephs D, Kumar P, Malmström PU, Van Hemelrijck M.

Scand J Urol. 2019 Jun 7:1-7. doi: 10.1080/21681805.2019.1624611. [Epub ahead of print]


A Nationwide Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.

Westergren DO, Gårdmark T, Lindhagen L, Chau A, Malmström PU.

J Urol. 2019 May 30:101097JU0000000000000350. doi: 10.1097/JU.0000000000000350. [Epub ahead of print]


Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe).

Jahnson S, Gårdmark T, Hosseini A, Jerlström T, Liedberg F, Malmström PU, Rosell J, Sherif A, Ströck V, Häggström C, Holmberg L, Aljabery F.

Scand J Urol. 2019 May 30:1-6. doi: 10.1080/21681805.2019.1621377. [Epub ahead of print]


No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.

Jerlström T, Chen R, Liedberg F, Andrén O, Ströck V, Aljabery FAS, Hosseini A, Sherif A, Malmström PU, Ullén A, Gårdmark T, Fall K.

World J Urol. 2019 Apr 24. doi: 10.1007/s00345-019-02770-2. [Epub ahead of print]


Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.

Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat AM, Konety B, Malmström PU, McKiernan J, O'Donnell M, Patel S, Pohar K, Resnick M, Sankin A, Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S.

Nat Rev Urol. 2019 Jun;16(6):377-386. doi: 10.1038/s41585-019-0184-4. Review.


Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.

Liedberg F, Hagberg O, Aljabery F, Gårdmark T, Hosseini A, Jahnson S, Jancke G, Jerlström T, Malmström PU, Sherif A, Ströck V, Häggström C, Holmberg L.

BJU Int. 2019 Sep;124(3):449-456. doi: 10.1111/bju.14767. Epub 2019 Apr 22.


Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial.

Kovács A, Stenmark Tullberg A, Werner Rönnerman E, Holmberg E, Hartman L, Sjöström M, Lundstedt D, Malmström P, Fernö M, Karlsson P.

J Clin Oncol. 2019 May 10;37(14):1179-1187. doi: 10.1200/JCO.18.02157. Epub 2019 Apr 2.


Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.

Häggström C, Garmo H, de Luna X, Van Hemelrijck M, Söderkvist K, Aljabery F, Ströck V, Hosseini A, Gårdmark T, Malmström PU, Jahnson S, Liedberg F, Holmberg L.

Cancer Med. 2019 May;8(5):2196-2204. doi: 10.1002/cam4.2126. Epub 2019 Apr 1.


Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?

Turker P, Segersten U, Malmström PU, Hemdan T.

Scand J Urol. 2019 Feb;53(1):45-50. doi: 10.1080/21681805.2019.1575467. Epub 2019 Feb 26.


Progress towards a Nordic standard for the investigation of hematuria: 2019.

Malmström PU, Skaaheim Haug E, Boström PJ, Gudjónsson S, Bjerggaard Jensen J.

Scand J Urol. 2019 Feb;53(1):1-6. doi: 10.1080/21681805.2018.1555187. Epub 2019 Jan 14.


Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.

Danielsson G, Malmström PU, Jahnson S, Wijkström H, Nyberg T, Thulin H.

Scand J Urol. 2018 Oct - Dec;52(5-6):377-384. doi: 10.1080/21681805.2018.1538162. Epub 2019 Jan 8.


Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.

Forsare C, Bak M, Falck AK, Grabau D, Killander F, Malmström P, Rydén L, Stål O, Sundqvist M, Bendahl PO, Fernö M.

BMC Cancer. 2018 Dec 7;18(1):1226. doi: 10.1186/s12885-018-5123-x.


Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.

Matikas A, Foukakis T, Moebus V, Greil R, Bengtsson NO, Steger GG, Untch M, Johansson H, Hellström M, Malmström P, Gnant M, Loibl S, Bergh J.

Ann Oncol. 2019 Jan 1;30(1):109-114. doi: 10.1093/annonc/mdy475.


Yoga Practice Reduces the Psychological Distress Levels of Prison Inmates.

Sfendla A, Malmström P, Torstensson S, Kerekes N.

Front Psychiatry. 2018 Sep 3;9:407. doi: 10.3389/fpsyt.2018.00407. eCollection 2018.


Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R.

World J Urol. 2018 Nov;36(11):1775-1781. doi: 10.1007/s00345-018-2450-0. Epub 2018 Aug 31.


Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.

Sjöström M, Staaf J, Edén P, Wärnberg F, Bergh J, Malmström P, Fernö M, Niméus E, Fredriksson I.

Breast Cancer Res. 2018 Jul 4;20(1):64. doi: 10.1186/s13058-018-0978-y.


Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes AJ, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Gontero P.

World J Urol. 2018 Oct;36(10):1621-1627. doi: 10.1007/s00345-018-2299-2. Epub 2018 May 2.


Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer.

Sjöström C, Thorstenson A, Ströck V, Hosseini-Aliabad A, Aljabery F, Liedberg F, Sherif A, Malmström PU, Rosell J, Gårdmark T, Jahnson S.

Scand J Urol. 2018 Jun;52(3):186-193. doi: 10.1080/21681805.2018.1462254. Epub 2018 Apr 20.


Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods.

Holfeld A, Valdés A, Malmström PU, Segersten U, Lind SB.

Anal Chem. 2018 May 1;90(9):5841-5849. doi: 10.1021/acs.analchem.8b00379. Epub 2018 Apr 13.


Choline-phosphate cytidylyltransferase-α as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder.

Hemdan T, Turker P, Malmström PU, Segersten U.

Scand J Urol. 2018 Jun;52(3):200-205. doi: 10.1080/21681805.2018.1439527. Epub 2018 Feb 23.


Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment.

Mertens C, Mora J, Ören B, Grein S, Winslow S, Scholich K, Weigert A, Malmström P, Forsare C, Fernö M, Schmid T, Brüne B, Jung M.

Oncoimmunology. 2017 Dec 22;7(3):e1408751. doi: 10.1080/2162402X.2017.1408751. eCollection 2018.


Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.

van Kessel KEM, van der Keur KA, Dyrskjøt L, Algaba F, Welvaart NYC, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Grimm MO, Hermann GG, Mogensen K, Hartmann A, Harving N, Petersen AC, Jensen JB, Junker K, Boormans JL, Real FX, Malats N, Malmström PU, Ørntoft TF, Zwarthoff EC.

Clin Cancer Res. 2018 Apr 1;24(7):1586-1593. doi: 10.1158/1078-0432.CCR-17-2719. Epub 2018 Jan 24.


Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.

Chan OTM, Furuya H, Pagano I, Shimizu Y, Hokutan K, Dyrskjøt L, Jensen JB, Malmstrom PU, Segersten U, Janku F, Rosser CJ.

Oncotarget. 2017 Sep 6;8(59):99707-99721. doi: 10.18632/oncotarget.20686. eCollection 2017 Nov 21.


Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.

Matikas A, Margolin S, Hellström M, Johansson H, Bengtsson NO, Karlsson L, Edlund P, Karlsson P, Lidbrink E, Linderholm B, Lindman H, Malmstrom P, Villman K, Foukakis T, Bergh J.

Breast Cancer Res Treat. 2018 Apr;168(2):349-355. doi: 10.1007/s10549-017-4599-4. Epub 2017 Nov 30.


Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).

Häggström C, Liedberg F, Hagberg O, Aljabery F, Ströck V, Hosseini A, Gårdmark T, Sherif A, Malmström PU, Garmo H, Jahnson S, Holmberg L.

BMJ Open. 2017 Sep 27;7(9):e016606. doi: 10.1136/bmjopen-2017-016606.


Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial.

Sjöström M, Lundstedt D, Hartman L, Holmberg E, Killander F, Kovács A, Malmström P, Niméus E, Werner Rönnerman E, Fernö M, Karlsson P.

J Clin Oncol. 2017 Oct 1;35(28):3222-3229. doi: 10.1200/JCO.2017.72.7263. Epub 2017 Jul 31.


Half a decade of fluorescence in the bladder.

Malmström PU.

Scand J Urol. 2017 Jun;51(3):219-227. doi: 10.1080/21681805.2017.1329903. No abstract available.


Drugs and risk of cancer.

Malmström PU.

Scand J Urol. 2017 Jun;51(3):212-218. doi: 10.1080/21681805.2017.1329905. No abstract available.


Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.

Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF.

Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2.


Non-muscle-invasive bladder cancer: a vision for the future.

Malmström PU, Agrawal S, Bläckberg M, Boström PJ, Malavaud B, Zaak D, Hermann GG.

Scand J Urol. 2017 Apr;51(2):87-94. doi: 10.1080/21681805.2017.1283359. Epub 2017 Feb 7. Review.


Evaluation of the diagnostic accuracy of UBC® Rapid in bladder cancer: a Swedish multicentre study.

Styrke J, Henriksson H, Ljungberg B, Hasan M, Silfverberg I, Einarsson R, Malmström PU, Sherif A.

Scand J Urol. 2017 Aug;51(4):293-300. doi: 10.1080/21681805.2017.1313309. Epub 2017 Apr 19.


Evidence in Urologic- and Pelvic-Surgery Research: Finding the IDEAL Way of Reporting.

Gerullis H, Barski D, Malmström PU, Sun X, Ecke TH.

Biomed Res Int. 2017;2017:2716759. doi: 10.1155/2017/2716759. Epub 2017 Mar 9. No abstract available.


Second-look resection for primary stage T1 bladder cancer: a population-based study.

Patschan O, Holmäng S, Hosseini A, Jancke G, Liedberg F, Ljungberg B, Malmström PU, Rosell J, Jahnson S.

Scand J Urol. 2017 Aug;51(4):301-307. doi: 10.1080/21681805.2017.1303846. Epub 2017 Apr 11.


Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer.

Malmström PU, Hemdan T, Segersten U.

Urol Oncol. 2017 Aug;35(8):532.e1-532.e6. doi: 10.1016/j.urolonc.2017.03.010. Epub 2017 Apr 25.


Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder.

Jancke G, Liedberg F, Aljabery F, Sherif A, Ströck V, Malmström PU, Hosseini-Aliabad A, Jahnson S.

Scand J Urol. 2017 Apr;51(2):124-129. doi: 10.1080/21681805.2017.1298156. Epub 2017 Mar 29.


Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen.

Rosell J, Nordenskjöld B, Bengtsson NO, Fornander T, Hatschek T, Lindman H, Malmström PO, Wallgren A, Stål O, Carstensen J.

Acta Oncol. 2017 Apr;56(4):614-617. doi: 10.1080/0284186X.2016.1273547. Epub 2017 Jan 12.


FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.

Beukers W, van der Keur KA, Kandimalla R, Vergouwe Y, Steyerberg EW, Boormans JL, Jensen JB, Lorente JA, Real FX, Segersten U, Orntoft TF, Malats N, Malmström PU, Dyrskjot L, Zwarthoff EC.

J Urol. 2017 Jun;197(6):1410-1418. doi: 10.1016/j.juro.2016.12.096. Epub 2016 Dec 31.


Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.

Foukakis T, von Minckwitz G, Bengtsson NO, Brandberg Y, Wallberg B, Fornander T, Mlineritsch B, Schmatloch S, Singer CF, Steger G, Egle D, Karlsson E, Carlsson L, Loibl S, Untch M, Hellström M, Johansson H, Anderson H, Malmström P, Gnant M, Greil R, Möbus V, Bergh J; Swedish Breast Cancer Group (SweBCG), the German Breast Group (GBG), and the Austrian Breast & Colorectal Cancer Study Group (ABCSG).

JAMA. 2016 Nov 8;316(18):1888-1896. doi: 10.1001/jama.2016.15865.


Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.

Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C, Grabau D, Rydén L, Stål O, Fernö M; South and South-East Swedish Breast Cancer Groups.

Acta Oncol. 2017 Jan;56(1):68-74. doi: 10.1080/0284186X.2016.1237778. Epub 2016 Oct 20.


Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.

van Kessel KE, Beukers W, Lurkin I, Ziel-van der Made A, van der Keur KA, Boormans JL, Dyrskjøt L, Márquez M, Ørntoft TF, Real FX, Segersten U, Malats N, Malmström PU, Van Criekinge W, Zwarthoff EC.

J Urol. 2017 Mar;197(3 Pt 1):590-595. doi: 10.1016/j.juro.2016.09.118. Epub 2016 Oct 13.


The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.

Witjes JA, Dalbagni G, Karnes RJ, Shariat S, Joniau S, Palou J, Serretta V, Larré S, di Stasi S, Colombo R, Babjuk M, Malmström PU, Malats N, Irani J, Baniel J, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Pisano F, Gontero P, Sylvester R.

Urol Oncol. 2016 Nov;34(11):484.e19-484.e25. doi: 10.1016/j.urolonc.2016.05.033. Epub 2016 Sep 14.


No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.

Killander F, Karlsson P, Anderson H, Mattsson J, Holmberg E, Lundstedt D, Holmberg L, Malmström P.

Eur J Cancer. 2016 Nov;67:57-65. doi: 10.1016/j.ejca.2016.08.001. Epub 2016 Sep 7.


Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder.

Kaasinen E, Wijkström H, Rintala E, Mestad O, Jahnson S, Malmström PU.

Scand J Urol. 2016 Oct;50(5):360-8. doi: 10.1080/21681805.2016.1210672. Epub 2016 Aug 15.


Supplemental Content

Loading ...
Support Center